Product NDC: | 68462-233 |
Proprietary Name: | Felodipine |
Non Proprietary Name: | Felodipine |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Felodipine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68462-233 |
Labeler Name: | Glenmark Generics, Inc. USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090365 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101220 |
Package NDC: | 68462-233-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-233-01) |
NDC Code | 68462-233-01 |
Proprietary Name | Felodipine |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-233-01) |
Product NDC | 68462-233 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Felodipine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101220 |
Marketing Category Name | ANDA |
Labeler Name | Glenmark Generics, Inc. USA |
Substance Name | FELODIPINE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |